Profound Competitors
| PROF Stock | USD 6.82 0.24 3.40% |
Profound Medical vs Armata Pharmaceuticals Correlation
Average diversification
The correlation between Profound Medical Corp and ARMP is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Profound Medical Corp and ARMP in the same portfolio, assuming nothing else is changed.
Moving against Profound Stock
| 0.93 | IHC | Inspiration Healthcare | PairCorr |
| 0.82 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.78 | IVF | INVO Fertility Symbol Change | PairCorr |
| 0.73 | AHC | Austco Healthcare | PairCorr |
| 0.68 | NTI | Neurotech International | PairCorr |
Profound Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Profound Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Profound and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Profound Medical Corp does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Profound Stock performing well and Profound Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Profound Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TLSI | 3.25 | 0.11 | 0.02 | 0.18 | 4.16 | 8.30 | 25.94 | |||
| MXCT | 3.17 | (0.85) | 0.00 | (0.47) | 0.00 | 5.44 | 16.52 | |||
| CATX | 5.25 | 1.32 | 0.21 | 0.84 | 5.01 | 8.14 | 77.44 | |||
| LNSR | 1.73 | 0.01 | 0.00 | 0.06 | 2.56 | 3.50 | 11.85 | |||
| AVR | 3.77 | 0.52 | 0.15 | 1.11 | 3.15 | 9.42 | 25.09 | |||
| NNOX | 3.78 | (0.54) | 0.00 | (0.39) | 0.00 | 9.44 | 36.87 | |||
| PRE | 3.75 | 0.47 | 0.11 | 0.35 | 3.87 | 8.75 | 22.19 | |||
| STIM | 5.38 | (0.78) | 0.00 | (0.20) | 0.00 | 10.55 | 28.95 | |||
| OWLT | 4.01 | 0.40 | 0.07 | 25.45 | 4.91 | 8.21 | 24.32 | |||
| ARMP | 5.30 | 0.89 | 0.14 | 0.50 | 5.83 | 14.73 | 38.51 |
Cross Equities Net Income Analysis
Compare Profound Medical Corp and related stocks such as TriSalus Life Sciences, MaxCyte, and Perspective Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TLSI | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (47.2 M) | (59.4 M) | (33.2 M) | (29.9 M) | (31.4 M) |
| MXCT | (2 M) | (2 M) | (2 M) | (958.2 K) | (1.8 M) | (1.4 M) | (3.3 M) | (9.9 M) | (8.9 M) | (12.9 M) | (11.8 M) | (19.1 M) | (23.6 M) | (37.9 M) | (41.1 M) | (36.9 M) | (35.1 M) |
| CATX | (437.6 K) | (2.8 M) | (3.5 M) | (3.9 M) | (6 M) | (3.7 M) | (4.7 M) | (6.2 M) | (4.8 M) | (3.3 M) | (3.2 M) | (7.3 M) | (14.7 M) | (46.5 M) | (79.3 M) | (71.4 M) | (67.8 M) |
| LNSR | (12.6 M) | (12.6 M) | (12.6 M) | (12.6 M) | (12.6 M) | (12.6 M) | (12.6 M) | (12.6 M) | (12.6 M) | (14.7 M) | (19.8 M) | (19.6 M) | (19.9 M) | (14.4 M) | (31.4 M) | (28.3 M) | (29.7 M) |
| AVR | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (17.2 M) | (30.6 M) | (46 M) | (76.3 M) | (68.7 M) | (65.2 M) |
| NNOX | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (22.6 M) | (43.5 M) | (61.8 M) | (105.2 M) | (60.8 M) | (53.5 M) | (48.2 M) | (50.6 M) |
| PRE | 142.3 M | 1.1 B | 1.1 B | 664 M | 1.1 B | 104.4 M | (20.1 M) | (20.1 M) | (20.1 M) | (20.1 M) | (1.9 M) | (174 M) | (190.5 M) | (62.7 M) | (46.3 M) | (41.7 M) | (39.6 M) |
| STIM | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (16.1 M) | (24.1 M) | (29 M) | (27.5 M) | (31.2 M) | (37.2 M) | (30.2 M) | (43.7 M) | (39.3 M) | (41.3 M) |
| OWLT | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (17.9 M) | (10.5 M) | (71.7 M) | (79.3 M) | (32.9 M) | (12.5 M) | (11.3 M) | (11.8 M) |
| ARMP | (5.1 M) | (3.8 M) | (1.1 M) | (64.6 M) | 23.1 M | (516 K) | (18.8 M) | (12.8 M) | (12.1 M) | (19.5 M) | (22.2 M) | (23.2 M) | (36.9 M) | (69 M) | (18.9 M) | (17 M) | (17.9 M) |
Profound Medical Corp and related stocks such as TriSalus Life Sciences, MaxCyte, and Perspective Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Profound Medical Corp financial statement analysis. It represents the amount of money remaining after all of Profound Medical Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Profound Medical Competitive Analysis
The better you understand Profound Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Profound Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Profound Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Profound Medical Competition Performance Charts
Five steps to successful analysis of Profound Medical Competition
Profound Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Profound Medical Corp in relation to its competition. Profound Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Profound Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Profound Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Profound Medical Corp, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Profound Medical position
In addition to having Profound Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Profound Medical Correlation with its peers. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.